world
Study Finds GLP-1 Medications Linked to Reduced Mental Health Risks
A study involving nearly 100,000 participants examined GLP-1 medications such as semaglutide, used in Ozempic. Researchers reported associations with lower risks of depression, anxiety, substance-use disorders, and related hospitalizations. The findings suggest potential mental health benefits alongside known effects on weight loss and diabetes management.
Substrate placeholder — needs reviewAudio version
Tap play to generate a narrated version.
A study published by an international group of researchers analyzed the effects of GLP-1 medications, including semaglutide, on nearly 100,000 participants. These medications are commonly used for weight loss and diabetes management. The research identified links to reduced risks for certain mental health conditions.
The study found that semaglutide use was associated with a 44 percent lower risk of depression and a 38 percent lower risk of anxiety disorders. Participants using semaglutide were 42 percent less likely to be hospitalized for mental health issues. Additionally, hospitalizations and sick leaves related to substance-use disorders decreased by 47 percent, with semaglutide also linked to a lower risk of suicidal behavior.
The research drew from data in Finland and Sweden, focusing on GLP-1 receptor agonists like semaglutide.
It compared outcomes for users versus non-users over time. The findings build on prior observations, such as a Swedish study associating GLP-1 medications with reduced risk of alcohol use disorder. " — Mark Taylor, professor at Griffith University in Australia (Newsweek) Researchers noted that alcohol-related issues can influence mood and anxiety.
The study did not establish causation for the observed associations. Further investigation is needed to understand underlying mechanisms.
Markku Lähteenvuo, research director at the University of Eastern Finland, described the association as quite strong.
Possible factors include reduced alcohol consumption, weight loss improving body image, better glycemic control in diabetes, or direct effects on the brain's reward system. The study could not determine the precise reasons for the mental health links. Previous research has explored other effects of Ozempic.
